Tubular adenomas with minor villous changes show molecular features characteristic of tubulovillous adenomas

American Journal of Surgical Pathology

Volumn 35, Issue 2, 2011, Pages 212-220

  Ishii, Tatsuhiro ^a,b,c   Notohara, Kenji ^d   Umapathy, Aarti ^a,b,e   Mallitt, Kylie Ann ^f   Chikuba, Hiroshi ^g   Moritani, Yukitoshi ^h   Tanaka, Noriaki ^c   Rosty, Christophe ^a,i   Matsubara, Nagahide ^c   Jass, Jeremy ^j   Leggett, Barbara ^a,b   Whitehall, Vicki ^a,e  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c OKAYAMA UNIVERSITY   (Japan)

^d KURASHIKI CENTRAL HOSPITAL   (Japan)

^e Clinical and Statewide Services Queensland Health ^*  (Australia)

^f Cancer and Population Studies Laboratory   (United States)

^g Chikuba Hospital for Gastrointestinal and Colorectal Surgery   (Japan)

^h Moritani Clinic of Colorectal Surgery   (Japan)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

^j ST MARK S HOSPITAL   (United Kingdom)

more..

Author keywords

KRAS; MGMT; p53; tubulovillous adenoma

Indexed keywords

B RAF KINASE; BETA CATENIN; BRAF PROTEIN, HUMAN; DNA; DNA METHYLTRANSFERASE; KRAS PROTEIN, HUMAN; MGMT PROTEIN, HUMAN; ONCOPROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN P53; RAS PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; COLON POLYP; COLORECTAL TUMOR; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; RETROSPECTIVE STUDY; VILLOUS ADENOMA;

ADENOMA, VILLOUS; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; COLONIC POLYPS; COLORECTAL NEOPLASMS; DNA MODIFICATION METHYLASES; DNA MUTATIONAL ANALYSIS; DNA REPAIR ENZYMES; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 79251569605     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318205df20     Document Type: Article

References (42)

1. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658-662.
2. Barry EL, Baron JA, Grau MV, et al. K-ras mutations in incident sporadic colorectal adenomas. Cancer. 2006;106:1036-1040.
3. Bertario L, Russo A, Sala P, et al. Predictors of metachronous colorectal neoplasms in sporadic adenoma patients. Int J Cancer. 2003;105:82-87.
4. Bos JL. The ras gene family and human carcinogenesis. Mutat Res. 1988;195:255-271.
5. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature (London). 1987;327: 293-297.
6. Brabletz T, Herrmann K, Jung A, et al. Expression of nuclear beta-catenin and c-myc is correlated with tumour size but not with proliferative activity of colorectal adenomas. Am J Pathol. 2000; 156:865-870.
7. Day DW, Jass JR, Price AB, et al. Morson and Dawson's Gastrointestinal Pathology. 4th ed. London, Oxford: Blackwell Scientific Publications; 2003.
8. Denis B, Peters C, et al. Diagnostic accuracy of community pathologists in the interpretation of colorectal polyps. Eur J Gastroenterol Hepatol. 2009;21:1153-1160.
9. Einspahr JG, Martinez ME, Jiang R, et al. Associations of Kiras protooncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics. Cancer Epidemiol Biomarkers Prev. 2006;15: 1443-1450.
10. Esteller M, Hamilton SR, Burger PC, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 1999;59:793-797.
11. Esteller M, Toyota M, Sanchez-Cespedes M, et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumourigenesis. Cancer Res. 2000;60: 2368-2371.
12. Esteller M, Risques RA, Toyota M, et al. Promoter hypermethyla-tion of the DNA repair gene O(6)-methylguanine-DNA methyl-transferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumourigenesis. Cancer Research. 2001;61:4689-4692.
13. Fearon ER, Vogelstein B. A genetic model for colorectal tumour-igenesis. Cell. 1990;61:759-767.
14. Hamilton SD, Vogelstein B, Kudo S, et al. Tumours of the colon and rectum: carcinoma of the colon and rectum. In: Hamilton SD, Aaltonen LA, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000:105-119.
15. Jass JR, Biden KG, Cummings M, et al. Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol. 1999;52:455-460.
16. Jass JR, Baker K, Zlobec I, et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a "fusion" pathway to colorectal cancer. Histopathology. 2006;49:121-131.
17. Kakar S, Deng G, Cun L, et al. CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component. Hum Pathol. 2008; 39:30-36.
18. Kaklamanis L, Gatter KC, Mortensen N, et al. p53 expression in colorectal adenomas. Am J Pathol. 1993;142:87-93.
19. Karamitopoulou E, Perentes E, Diamantis I, et al. p53 protein expression in colorectal adenomas: an immunohistochemical study using an antigen retrieval system. Histopathology. 1995; 27:517-523.
20. Konishi F, Morson BC. Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol. 1982;35:830-841.
21. Konishi K, Yamochi T, Makino R, et al. Molecular differences between sporadic serrated and conventional colorectal adenomas. Clin Cancer Res. 2004;10:3082-3090.
22. Loeve F, van Ballegooijen M, Snel P, et al. Colorectal cancer risk after colonoscopic polypectomy: a population-based study and literature search. Eur J Cancer. 2005;41:416-422.
23. Maltzman T, Knoll K, Martinez ME, et al. Kiras protooncogene mutations in sporadic colorectal adenomas: relationship to histolo-gic and clinical characteristics. Gastroenterology. 2001;121: 302-309.
24. Martnez ME, Sampliner R, Marshall JR, et al. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology. 2001;120:1077.
25. Nusko G, Sachse R, Mansmann U, et al. K-RAS-2 gene mutations as predictors of metachronous colorectal adenomas. Scand J Gastroenterol. 1997;32:1035-1041.
26. Nusko G, Hahn EG, Mansmann U. Characteristics of metachro-nous colorectal adenomas found during long-term follow-up: analysis of four subsequent generations of adenoma recurrence. Scand J Gastroenterol. 2009;44:736-744.
27. O'Brien MJ, Winawer SJ, Zauber AG, et al. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology. 1990;98:371-379.
28. O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006;30:1491-1501.
29. Oliveira C, Velho S, Moutinho C, et al. KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene. 2007;26:158-163.
30. Pignatelli M, Stamp GW, Kafiri G, et al. Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer. 1992;50:683-688.
31. Samowitz WS, Slattery ML, Sweeney C, et al. APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res. 2007;5:165-170.
32. Smith G, Carey FA, Beattie J, et al. Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci USA. 2002;99:9433-9438.
33. Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006;131: 1400-1407.
34. Valizadeh A, Karayiannakis AJ, el-Hariry I, et al. Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps. Am J Pathol. 1997;150: 1977-1984.
35. van Stolk RU, Beck GJ, Baron JA, et al. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up: the polyp prevention study group. Gastroenterology. 1998;115:13-18.
36. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumour development. N Engl J Med. 1988;319: 525-532.
37. Whitehall VLJ, Tran K, Umapathy A, et al. A mulitcenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting. J Mol Biol. 2009;11:543-552.
38. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colono-scopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin. 2006;56:143-159; quiz 84-85.
39. Yamamoto T, Konishi K, Yamochi T, et al. No major tumourigenic role for b-catenin in serrated as opposed to conventional colorectal adenomas. Brit J Cancer. 2003;89:152-157.
40. Yang G, Zheng W, Sun QR, et al. Pathologic features of initial adenomas as predictors for metachronous adenomas of the rectum. J Natl Cancer Inst. 1998;90:1661-1665.
41. Young J, Barker MA, Simms LA, et al. Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol. 2005;3:254-263.
42. Yuen ST, Davies H, Chan TL, et al. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res. 2002;62:6451-6455.